Aaron Sandoski

Aaron brings over 15 years of early-stage medtech investing to MCF.

Aaron joined in 2020 as a founding Partner of the Medtech Convergence Fund (MCF). He is a Managing Director of Norwich Ventures, a predecessor to MCF.

Aaron is the Managing Director of Norwich Ventures, an early-stage medtech VC he co-founded in 2004. His investments at Norwich include Affera, Arterys, IonPath, Lexington Medical, Podimetrics, Vaxess, Intelligent Bio-systems (acquired by Qiagen) and Rhythmia Medical (acquired by Boston Scientific). Previously, Aaron worked for DEKA, the engineering think tank of Dean Kamen, and two start-up companies that were acquired. Aaron began his career as a consultant at McKinsey & Company.

Aaron serves on the Board of MassMEDIC and regularly guest lectures on medical technology, innovation, and finance at Harvard and Stanford. He is the author of How the Wise Decide, a book on decision-making that has been translated into 11 foreign languages. Aaron enjoys finding new adventures with his family and is passionate about classic cars.

Academic credentials

AB, Chemistry and Economics, Dartmouth College; MBA, Harvard Business School